上海思璞锐

Shanghai Sipure Biotechnology is a specialized biotechnology company focused on drug discovery through its proprietary DNA-encoded library (DEL) technology platform. The company provides high-throughput screening services and lead optimization to pharmaceutical and biotech partners, enabling the rapid identification of small molecule candidates against challenging biological targets. Sipure's platform integrates advanced chemical synthesis, molecular biology, and bioinformatics to manage vast libraries of billions of compounds. By leveraging its DEL expertise, the company aims to accelerate the early-stage drug development process and reduce the costs associated with traditional high-throughput screening.